Apps Like DAPT Risk Calculator for iPhone and iPad
Calculate score and evaluate therapy continuation
Calculate scores for patients 12 months post-PCI. Input patient data to determine benefit/ ratio of continuing . Provide numerical scores between -2 and +9. Help clinicians decide on continuation or discontinuation.
DAPT Risk Calculator screenshots
Ranked alternatives
Showing 141–160 of 1,000 ranked alternatives.



iChoose Kidney - Educational
Emory University
Support informed kidney failure decisions now.
The app provides a decision support tool for healthcare professionals and patient educators. It helps ESRD patients make informed decisions about kidney failure treatment options by presenting risk prediction models.




eGFR Calculators
National Kidney Foundation
Estimate kidney function with calculators.
The app provides five eGFR calculators for medical professionals, including CKD-EPI Creatinine 2021 and Revised Bedside Schwartz Formula. It also offers information on glomerular filtration rate, chronic kidney disease, and clinical use.




Triaj
Triaj, Inc.
Diagnose, treat, and care for patients remotely
Enables healthcare professionals to access clinical decision support for pediatric and adolescent care. It offers treatment guidelines, patient management tools, and real-time communication features.







CathSource
ECGsource LLC
Cardiac catheterization and angiography reference.
The app provides a medical reference for cardiac catheterization and angiography. It includes a searchable index of specialized topics, a database of videos, and a collection of images with formulas and tables.


DiRA - Diabetes Remission
Beijing Dnurse Technology Ltd.
Track glucose levels and adjust diet
Track blood glucose levels, set reminders for medication and meals. Log physical activity and dietary intake. Monitor HbA1C trends and receive personalized recommendations. Sync data with healthcare providers for ongoing management.
How we rank alternatives
Apps are ranked by functional similarity, category fit, rating confidence, and popularity.